Vincent Wai-Sun Wong

Epidemiology · 2004–2023

A researcher in the Science corpus: 18 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Vincent Wai-Sun Wong trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Harrison
  2. D. Kleiner

Who trusts Vincent Wai-Sun Wong overall

  1. Asociacion Latinoamericana para el Estudio del Higado
  2. Z. Younossi
  3. G. Vernon

Papers from Vincent Wai-Sun Wong's perspective

Ordered by how strongly the researchers Vincent Wai-Sun Wong trusts endorse each paper. Same corpus, a different order for every researcher.

  1. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
  2. Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
  3. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
  4. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. (Clinical Gastroenterology and Hepatology)
  5. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American… (Circulation)
  6. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. (Gastroenterology)
  7. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (Hepatology)
  8. THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE IN CHILDREN: A FOLLOW-UP STUDY FOR UP TO 20-YEARS (Gut)
  9. Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis (Hepatology)
  10. USE OF THE FIB4 INDEX FOR NON-INVASIVE EVALUATION OF FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (Clinical Gastroenterology and Hepatology)

Their papers